Trademark: 86178762
Status Date
Friday, January 21, 2022
Registration Number
4773694
Registration Date
Tuesday, July 14, 2015
Filing Date
Wednesday, January 29, 2014
Published for Opposition
Tuesday, June 10, 2014
Cancellation Date
Friday, January 21, 2022
42 Conducting clinical trials for others on the safety and effectiveness of drugs; conducting clinical trials on the safety and effectiveness of apremilast; conducting clinical trials for others on the safety and effectiveness of drugs for psoriasis; providing medical and scientific research information in the field of clinical trials
Jan 21, 2022
Cancelled Sec. 8 (6-Yr)
Jul 14, 2020
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jul 28, 2015
Teas Change Of Correspondence Received
Jul 14, 2015
Registered-Principal Register
Jun 11, 2015
Notice Of Acceptance Of Statement Of Use E-Mailed
Jun 10, 2015
Allowed Principal Register - Sou Accepted
Jun 9, 2015
Assigned To Examiner
Jun 9, 2015
Assigned To Examiner
May 18, 2015
Assigned To Examiner
May 17, 2015
Statement Of Use Processing Complete
Apr 13, 2015
Use Amendment Filed
May 15, 2015
Case Assigned To Intent To Use Paralegal
Apr 13, 2015
Teas Statement Of Use Received
Apr 7, 2015
Assigned To Examiner
Jan 7, 2015
Notice Of Approval Of Extension Request E-Mailed
Jan 5, 2015
Extension 1 Granted
Jan 5, 2015
Extension 1 Filed
Jan 5, 2015
Teas Extension Received
Aug 5, 2014
Noa E-Mailed - Sou Required From Applicant
Jun 10, 2014
Official Gazette Publication Confirmation E-Mailed
Jun 10, 2014
Published For Opposition
May 21, 2014
Notification Of Notice Of Publication E-Mailed
May 1, 2014
Approved For Pub - Principal Register
Apr 30, 2014
Assigned To Examiner
Feb 10, 2014
New Application Office Supplied Data Entered In Tram
Feb 1, 2014
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
